ARCHIVES

Therapeutic Modalities Improve Patient Quality of Life In Trials

This article is from The Cancer Letter archive.

Vol. 27 No. 2 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor: IOM Study Welcome For “Omic” Research

October 29, 2010

FASEB Urges Congress To Fund Stem Cell Research.

July 27, 2001

FDA Issues MedWatch Warning, Begins Safety Review Of Prostate Cancer Drugs

May 7, 2010

Cooperative Groups: Insurers Agree To Cover Patient Care Costs In Group Trials

September 26, 1997

Robert Cook-Deegan On Implications of Appelate Court Ruling In Myriad Case Ruling

August 5, 2011

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013